KalVista Pharmaceuticals (KALV) Return on Sales (QoQ) (2014 - 2025)

KalVista Pharmaceuticals (KALV) Return on Sales (QoQ) (2014 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 KalVista Pharmaceuticals 1.36 Bn 1.36 Bn 49.41 Mn

Historic Data

Download Data
DateValue
Jul 31, 2025 4.00
Apr 30, 2020 7.00
Jan 31, 2020 -6.00
Oct 31, 2019 0.00
Jul 31, 2019 1.00
Apr 30, 2019 -2.00
Jan 31, 2019 -1.00
Oct 31, 2018 1.00
Jul 31, 2018 -1.00
Apr 30, 2018 1.00
Jan 31, 2018 4.00
Oct 31, 2017 57.00
Jul 31, 2017 -18.00
Apr 30, 2017 -12.00
Jan 31, 2017 -12.00
Oct 31, 2016 -15.00
Mar 31, 2016 -215.00
Dec 31, 2015 -19.00
Sep 30, 2015 51.00
Jun 30, 2015 -21.00